Samuel R Saks Insider Trading $DMI Assertio Therapeutics, Inc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Samuel R Saks.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Samuel R Saks. Samuel R Saks is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in DEPOMED INC ($DMI) and Chief Development Officer in Protagonist Therapeutics, Inc ($PTGX) and Chief Medical Officer in Protagonist Therapeutics, Inc ($PTGX) and Director in Tonix Pharmaceuticals Holding Corp. ($TNXP) and Chief Development Officer in Auspex Pharmaceuticals, Inc. ($ASPX).

Samuel R Saks in Assertio Therapeutics, Inc

Trading Symbol: DMI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samuel R Saks: Director
Holdings: 5,099 shares
Latest Transaction: May 20 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Samuel R Saks in Assertio Therapeutics, Inc

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, DMI, ASPX, PDLI, PTGX, TNXP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 20 2016	DMI	DEPOMED INC	Saks Samuel R	Director	Option Exercise	A	0.00	3,131	0	3,131
May 20 2016	DMI	DEPOMED INC	Saks Samuel R	Director	Option Exercise	A	19.16	7,669	146,938	7,669
May 13 2016	DMI	DEPOMED INC	Saks Samuel R	Director	Payment of Exercise	F	17.52	734	12,860	5,099	5.8 K to 5.1 K (-12.58 %)
Dec 03 2015	DMI	DEPOMED INC	Saks Samuel R	Director	Payment of Exercise	F	19.00	966	18,354	2,897	3.9 K to 2.9 K (-25.01 %)
May 13 2015	DMI	DEPOMED INC	Saks Samuel R	Director	Option Exercise	A	0.00	2,936	0	2,936
May 13 2015	DMI	DEPOMED INC	Saks Samuel R	Director	Option Exercise	A	20.43	7,857	160,519	7,857

Page: 1